24-24 April 2023
Qmed+
REGISTER NOW
keyboard_arrow_left See all news

Recent News

10 Jan, 2023 /
Qosina
Qosina introduces Irradiate to Order service for single-use bioprocess components
Qosina introduces an Irradiate to Order service for its single-use bioprocess component ...
09 Jan, 2023 /
Qosina
Qosina Announces Partnership with ILC Dover and Expanded Portfolio of Liquid Bag Chambers
Qosina announces a partnership with ILC Dover, a leader in the innovative design and pro...
05 Jan, 2023 /
Life Science Outsourcing, Inc.
Life Science Outsourcing Completes Acquisition of J-Pac Medical
Expands into biomaterials and diagnostics end-markets, broadens service offerings, and s...
04 Jan, 2023 /
Qosina
Qosina introduces AseptiQuik® G DC Series Connectors
Qosina announces the addition of the AseptiQuik® G DC Series connectors to its extensiv...
17 Nov, 2022 /
PTI Engineered Plastics, Inc.
PTI Engineered Plastics Receives MedAccred® Plastics Continuing Accreditation
PTI Engineered Plastics recognized for its commitment to continual improvement in medica...
HS Design Inc.
/ 18 Dec, 2019
keyboard_arrow_left See all news

HSD Pioneering Sight Controlled UI Within Augmented Reality

The system includes proprietary software that is loaded on a Data Manager PC and the Head Mounted Display (HMD, Microsoft HoloLens). The HMD enables users to have meaningful interactions with patient specific 3D cardiac models and electrical maps that are presented in a mixed reality environment. In addition, the system displays a real-time representation of catheter locations based on electro-anatomic mapping and uses shared models to allow for collaboration.

The SentiAR system can be fully controlled through the user’s gaze allowing the user to interact with the system while simultaneously performing important procedural tasks with their hands. This gaze-controlled user experience is an ergonomic breakthrough for interventional procedures. HSD helped SentiAR to pioneer and develop the user interface and interaction within this realm of intra-procedural sight-controlled operation. HSD's UI/UX and Human Factors Teams combined resources with SentiAR's Software team to understand the technological and environment surrounding the EI procedures. From there, the team provided user testing to best develop an intuitive and simple to use gaze controlled interface for the wearable control center that met with FDA HFE guidance.

 

About SentiAR: SentiAR’s mission is to transform the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient.The visualization is fully controllable “hands-free” by the clinician, providing an ergonomic breakthrough for the treatment and analysis of cardiac arrhythmias within an interventional catheter lab environment. SentiAR is developing the platform for eventual FDA submission. For more information about SentiAR, please visit: https://sentiar.com

About HSD: HSD is an award winning, user centered product development firm with a focus in the medical, healthcare, and life science marketplace. For over 40 years, HSD has been recognized for expertise in the areas of design research, strategy, human factors, user experience, industrial design, and mechanical engineering. HSD is a FDA compliant and ISO 13485 certified organization with team members proudly serving on the AAMI Human Factors Committee and assisting with Use and Usability guidance documents (ISO 62366 and IEC 62366). By approaching products from a user-centered perspective, HSD is confident in designing and developing products for a diverse environment. For more information about HSD, please visit: https://hs-design.com

Processing. Please wait.
Loading...